The Gastric Motility Disorder Drug market report offers in-dept analysis on the global market size, market share, market growth, sales analysis, regional analysis, market developments, opportunities, and forecasts that will help you in strategizing and expanding your business.

As per the most recent analysis conducted by our research team, the global Gastric Motility Disorder Drug market size is projected to reach US$ XX million by 2027 from US $ XX million in 2020 at a CAGR of XX% during 2021-2027.

The report included detailed analysis on the Gastric Motility Disorder Drug production capacity, its market share by manufacturers, growth rate, regional production capacity, ex-factory rate, and other important data points. The report also covers Gastric Motility Disorder Drug consumption globally as well as thorough bifurcation into regional and country wise consumption.

The research team goes an additional mile to comprehensively cover other important aspects on Gastric Motility Disorder Drug market such as the market dynamics, market segmentation, competition, growth prospects, and growth strategies. The buyers of this report will have access to exclusive data that covers market share by applications, manufacturers, regions, and countries. The document also covers market size by type, market competition by manufacturers, sales volume, growth rate, revenue, price and gross margins. Moreover, the authors of this report provide authentic calculations and estimations for global revenue and volume by type segments for Gastric Motility Disorder Drug market covering the period 2016-2027.

This report includes the following key manufacturers. We can also add other companies of your choice and customize the report as per your requirements.

• Theravance, Inc.
• Helsinn Healthcare S.A.
• Concert Pharmaceuticals, Inc.
• Targacept, Inc.
• ChironWells GmbH

Market Segment by Type

• Velusetrag
• Ipamorelin
• TD-8954
• Others

Market Segment by Application

• Hospital
• Clinic
• Home Use

Market Segment by Regions and Countries

• North America (United States, Canada, Mexico)
• Asia-Pacific (China, India, Japan, Taiwan, South Korea, Australia, Indonesia, Singapore, Malaysia, Rest of Asia-Pacific)
• Europe (Germany, France, UK, Italy, Spain, Russia, Rest of Europe)
• Central & South America (Brazil, Argentina, Rest of South America)
• Middle East & Africa (Saudi Arabia, UAE, Turkey, Rest of Middle East & Africa)

The study objectives of this report are:

• Overview of the Gastric Motility Disorder Drug market
• Analysis on key market segments
• Key manufacturer analysis based on production, sales, and revenue
• Gastric Motility Disorder Drug market regional and country wise analysis for production and consumption
• Study the forecast of market in respect to manufacturers, segments, and regions
• Identify significant trends and factors driving the market growth
• Analyse the available opportunities in the market by tracing high growth segments
• Analyse competitive developments like acquisitions, expansions, product launches, agreements, etc.
• Study the growth strategies of key manufacturers
• SWOT analysis

In this study, the years considered to estimate the market size of Gastric Motility Disorder Drug are as follows:

History Year: 2016-2020

Base Year: 2020

Estimated Year: 2021

Forecast Year 2021 to 2027

Available Customizations

Market Research Place offers customizations according to the client's specific needs. The report can be customized on the basis of manufacturers, regions, applications, etc. Contact us to know more about the customization options.

1 Report Overview

1.1 Research Scope

1.2 Market Segment by Type

1.2.1 Global Gastric Motility Disorder Drug Market Size Growth Rate by Type

1.2.2 Velusetrag

1.2.3 Ipamorelin

1.2.4 TD-8954

1.2.5 Others

1.3 Market Segment by Application

1.3.1 Global Gastric Motility Disorder Drug Market Share by Application (2016 VS 2021 VS 2027)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Home Use

1.4 Study Objectives

1.5 Years Considered

2 Market Perspective

2.1 Global Gastric Motility Disorder Drug Market Size (2016-2027)

2.1.1 Global Gastric Motility Disorder Drug Revenue (2016-2027)

2.1.2 Global Gastric Motility Disorder Drug Sales (2016-2027)

2.2 Global Gastric Motility Disorder Drug Market Size across Key Geographies Worldwide: 2016 VS 2021 VS 2027

2.2.1 Global Gastric Motility Disorder Drug Sales by Regions (2016-2021)

2.2.2 Global Gastric Motility Disorder Drug Revenue by Regions (2016-2021)

2.3 Global Gastric Motility Disorder Drug Market Size Forecast by Region

2.3.1 Global Gastric Motility Disorder Drug Sales Forecast by Region (2022-2027)

2.3.2 Global Gastric Motility Disorder Drug Revenue Forecast by Region (2022-2027)

2.4 Global Top Gastric Motility Disorder Drug Regions (Countries) Ranking by Market Size

2.5 Gastric Motility Disorder Drug Industry Trends

2.5.1 Gastric Motility Disorder Drug Market Trends

2.5.2 Gastric Motility Disorder Drug Market Drivers

2.5.3 Gastric Motility Disorder Drug Market Challenges

2.5.4 Gastric Motility Disorder Drug Market Restraints

3 Competitive Landscape by Manufacturers

3.1 Global Top Gastric Motility Disorder Drug Manufacturers by Sales (2016-2021)

3.1.1 Global Gastric Motility Disorder Drug Sales by Manufacturers (2016-2021)

3.1.2 Global Gastric Motility Disorder Drug Sales Market Share by Manufacturers (2016-2021)

3.1.3 Global 5 and 10 Largest Manufacturers by Gastric Motility Disorder Drug Sales in 2020

3.2 Global Top Manufacturers Gastric Motility Disorder Drug by Revenue

3.2.1 Global Gastric Motility Disorder Drug Revenue by Manufacturers (2016-2021)

3.2.2 Top Gastric Motility Disorder Drug Manufacturers Covered: Ranking by Revenue

3.2.3 Global Gastric Motility Disorder Drug Revenue Share by Manufacturers (2016-2021)

3.2.4 Global Gastric Motility Disorder Drug Market Concentration Ratio (CR5 and HHI)

3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastric Motility Disorder Drug as of 2020)

3.4 Global Gastric Motility Disorder Drug Average Selling Price (ASP) by Manufacturers

3.5 Key Manufacturers Gastric Motility Disorder Drug Plants/Factories Distribution and Area Served

3.6 Date of Key Manufacturers Enter into Gastric Motility Disorder Drug Market

3.7 Key Manufacturers Gastric Motility Disorder Drug Product Offered

3.8 Mergers & Acquisitions, Expansion Plans

4 Global Gastric Motility Disorder Drug Market Size by Type

4.1 Global Gastric Motility Disorder Drug Historic Market Review by Type (2016-2021)

4.1.1 Global Gastric Motility Disorder Drug Sales Market Share by Type (2016-2021)

4.1.2 Global Gastric Motility Disorder Drug Revenue Market Share by Type (2016-2021)

4.1.3 Gastric Motility Disorder Drug Price by Type (2016-2021)

4.2 Global Gastric Motility Disorder Drug Market Estimates and Forecasts by Type (2022-2027)

4.2.1 Global Gastric Motility Disorder Drug Sales Forecast by Type (2022-2027)

4.2.2 Global Gastric Motility Disorder Drug Revenue Forecast by Type (2022-2027)

4.2.3 Gastric Motility Disorder Drug Price Forecast by Type (2022-2027)

5 Global Gastric Motility Disorder Drug Market Size by Application

5.1 Global Gastric Motility Disorder Drug Historic Market Review by Application (2016-2021)

5.1.1 Global Gastric Motility Disorder Drug Sales Market Share by Application (2016-2021)

5.1.2 Global Gastric Motility Disorder Drug Revenue Market Share by Application (2016-2021)

5.1.3 Gastric Motility Disorder Drug Price by Application (2016-2021)

5.2 Global Gastric Motility Disorder Drug Market Estimates and Forecasts by Application (2022-2027)

5.2.1 Global Gastric Motility Disorder Drug Sales Forecast by Application (2022-2027)

5.2.2 Global Gastric Motility Disorder Drug Revenue Forecast by Application (2022-2027)

5.2.3 Gastric Motility Disorder Drug Price Forecast by Application (2022-2027)

6 North America

6.1 North America Gastric Motility Disorder Drug Sales Breakdown by Company

6.1.1 North America Gastric Motility Disorder Drug Sales by Company (2016-2027)

6.1.2 North America Gastric Motility Disorder Drug Revenue by Company (2016-2027)

6.2 North America Gastric Motility Disorder Drug Market Size by Type (2016-2027)

6.2.1 North America Gastric Motility Disorder Drug Sales by Type (2016-2027)

6.2.2 North America Gastric Motility Disorder Drug Revenue by Type (2016-2027)

6.3 North America Gastric Motility Disorder Drug Market Size by Application (2016-2027)

6.3.1 North America Gastric Motility Disorder Drug Sales by Application (2016-2027)

6.3.2 North America Gastric Motility Disorder Drug Revenue by Application (2016-2027)

6.4 North America Gastric Motility Disorder Drug Market Size by Country

6.4.1 North America Gastric Motility Disorder Drug Sales by Country (2016-2027)

6.4.2 North America Gastric Motility Disorder Drug Revenue by Country (2016-2027)

6.4.3 U.S.

6.4.4 Canada

7 Europe

7.1 Europe Gastric Motility Disorder Drug Sales Breakdown by Company

7.1.1 Europe Gastric Motility Disorder Drug Sales by Company (2016-2027)

7.1.2 Europe Gastric Motility Disorder Drug Revenue by Company (2016-2027)

7.2 Europe Gastric Motility Disorder Drug Market Size by Type (2016-2027)

7.2.1 Europe Gastric Motility Disorder Drug Sales by Type (2016-2027)

7.2.2 Europe Gastric Motility Disorder Drug Revenue by Type (2016-2027)

7.3 Europe Gastric Motility Disorder Drug Market Size by Application (2016-2027)

7.3.1 Europe Gastric Motility Disorder Drug Sales by Application (2016-2027)

7.3.2 Europe Gastric Motility Disorder Drug Revenue by Application (2016-2027)

7.4 Europe Gastric Motility Disorder Drug Market Size by Country

7.4.1 Europe Gastric Motility Disorder Drug Sales by Country (2016-2027)

7.4.2 Europe Gastric Motility Disorder Drug Revenue by Country (2016-2027)

7.4.3 Germany

7.4.4 France

7.4.5 U.K.

7.4.6 Italy

7.4.7 Russia

8 Asia Pacific

8.1 Asia Pacific Gastric Motility Disorder Drug Sales Breakdown by Company

8.1.1 Asia Pacific Gastric Motility Disorder Drug Sales by Company (2016-2027)

8.1.2 Asia Pacific Gastric Motility Disorder Drug Revenue by Company (2016-2027)

8.2 Asia Pacific Gastric Motility Disorder Drug Market Size by Type (2016-2027)

8.2.1 Asia Pacific Gastric Motility Disorder Drug Sales by Type (2016-2027)

8.2.2 Asia Pacific Gastric Motility Disorder Drug Revenue by Type (2016-2027)

8.3 Asia Pacific Gastric Motility Disorder Drug Market Size by Application (2016-2027)

8.3.1 Asia Pacific Gastric Motility Disorder Drug Sales by Application (2016-2027)

8.3.2 Asia Pacific Gastric Motility Disorder Drug Revenue by Application (2016-2027)

8.4 Asia Pacific Gastric Motility Disorder Drug Market Size by Regions

8.4.1 Asia Pacific Gastric Motility Disorder Drug Sales by Regions

8.4.2 Asia Pacific Gastric Motility Disorder Drug Revenue by Regions

8.4.3 China

8.4.4 Japan

8.4.5 South Korea

8.4.6 India

8.4.7 Australia

8.4.8 Taiwan

8.4.9 Indonesia

8.4.10 Thailand

8.4.11 Malaysia

8.4.12 Philippines

8.4.13 Vietnam

9 Latin America

9.1 Latin America Gastric Motility Disorder Drug Sales Breakdown by Company

9.1.1 Latin America Gastric Motility Disorder Drug Sales by Company (2016-2027)

9.1.2 Latin America Gastric Motility Disorder Drug Revenue by Company (2016-2027)

9.2 Latin America Gastric Motility Disorder Drug Market Size by Type (2016-2027)

9.2.1 Latin America Gastric Motility Disorder Drug Sales by Type (2016-2027)

9.2.2 Latin America Gastric Motility Disorder Drug Revenue by Type (2016-2027)

9.3 Latin America Gastric Motility Disorder Drug Market Size by Application (2016-2027)

9.3.1 Latin America Gastric Motility Disorder Drug Sales by Application (2016-2027)

9.3.2 Latin America Gastric Motility Disorder Drug Revenue by Application (2016-2027)

9.4 Latin America Gastric Motility Disorder Drug Market Size by Country

9.4.1 Latin America Gastric Motility Disorder Drug Sales by Country (2016-2027)

9.4.2 Latin America Gastric Motility Disorder Drug Revenue by Country (2016-2027)

9.4.3 Mexico

9.4.4 Brazil

9.4.5 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Gastric Motility Disorder Drug Sales Breakdown by Company

10.1.1 Middle East and Africa Gastric Motility Disorder Drug Sales by Company (2016-2027)

10.1.2 Middle East and Africa Gastric Motility Disorder Drug Revenue by Company (2016-2027)

10.2 Middle East and Africa Gastric Motility Disorder Drug Market Size by Type (2016-2027)

10.2.1 Middle East and Africa Gastric Motility Disorder Drug Sales by Type (2016-2027)

10.2.2 Middle East and Africa Gastric Motility Disorder Drug Revenue by Type (2016-2027)

10.3 Middle East and Africa Gastric Motility Disorder Drug Market Size by Application (2016-2027)

10.3.1 Middle East and Africa Gastric Motility Disorder Drug Sales by Application (2016-2027)

10.3.2 Middle East and Africa Gastric Motility Disorder Drug Revenue by Application (2016-2027)

10.4 Middle East and Africa Gastric Motility Disorder Drug Market Size by Country

10.4.1 Middle East and Africa Gastric Motility Disorder Drug Sales by Country (2016-2027)

10.4.2 Middle East and Africa Gastric Motility Disorder Drug Revenue by Country (2016-2027)

10.4.3 Turkey

10.4.4 Saudi Arabia

10.4.5 UAE

11 Company Profiles

11.1 Theravance, Inc.

11.1.1 Theravance, Inc. Corporation Information

11.1.2 Theravance, Inc. Overview

11.1.3 Theravance, Inc. Gastric Motility Disorder Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.1.4 Theravance, Inc. Gastric Motility Disorder Drug Products and Services

11.1.5 Theravance, Inc. Gastric Motility Disorder Drug SWOT Analysis

11.1.6 Theravance, Inc. Recent Developments

11.2 Helsinn Healthcare S.A.

11.2.1 Helsinn Healthcare S.A. Corporation Information

11.2.2 Helsinn Healthcare S.A. Overview

11.2.3 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.2.4 Helsinn Healthcare S.A. Gastric Motility Disorder Drug Products and Services

11.2.5 Helsinn Healthcare S.A. Gastric Motility Disorder Drug SWOT Analysis

11.2.6 Helsinn Healthcare S.A. Recent Developments

11.3 Concert Pharmaceuticals, Inc.

11.3.1 Concert Pharmaceuticals, Inc. Corporation Information

11.3.2 Concert Pharmaceuticals, Inc. Overview

11.3.3 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.3.4 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Products and Services

11.3.5 Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug SWOT Analysis

11.3.6 Concert Pharmaceuticals, Inc. Recent Developments

11.4 Targacept, Inc.

11.4.1 Targacept, Inc. Corporation Information

11.4.2 Targacept, Inc. Overview

11.4.3 Targacept, Inc. Gastric Motility Disorder Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.4.4 Targacept, Inc. Gastric Motility Disorder Drug Products and Services

11.4.5 Targacept, Inc. Gastric Motility Disorder Drug SWOT Analysis

11.4.6 Targacept, Inc. Recent Developments

11.5 ChironWells GmbH

11.5.1 ChironWells GmbH Corporation Information

11.5.2 ChironWells GmbH Overview

11.5.3 ChironWells GmbH Gastric Motility Disorder Drug Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2016-2021)

11.5.4 ChironWells GmbH Gastric Motility Disorder Drug Products and Services

11.5.5 ChironWells GmbH Gastric Motility Disorder Drug SWOT Analysis

11.5.6 ChironWells GmbH Recent Developments

12 Value Chain and Sales Channels Analysis

12.1 Gastric Motility Disorder Drug Value Chain Analysis

12.2 Gastric Motility Disorder Drug Key Raw Materials

12.2.1 Key Raw Materials

12.2.2 Raw Materials Key Suppliers

12.3 Gastric Motility Disorder Drug Production Mode & Process

12.4 Gastric Motility Disorder Drug Sales and Marketing

12.4.1 Gastric Motility Disorder Drug Sales Channels

12.4.2 Gastric Motility Disorder Drug Distributors

12.5 Gastric Motility Disorder Drug Customers

13 Research Findings and Conclusion

14 Appendix

14.1 Research Methodology

14.1.1 Methodology/Research Approach

14.1.2 Data Source

14.2 Author Details

14.3 Disclaimer

List of Tables

Table 1. Global Gastric Motility Disorder Drug Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)

Table 2. Major Manufacturers of Velusetrag

Table 3. Major Manufacturers of Ipamorelin

Table 4. Major Manufacturers of TD-8954

Table 5. Major Manufacturers of Others

Table 6. Global Gastric Motility Disorder Drug Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)

Table 7. Global Market Gastric Motility Disorder Drug Market Size (US$ Million) by Region: 2016 VS 2021 VS 2027

Table 8. Global Gastric Motility Disorder Drug Sales by Region (2016-2021) & (K Pcs)

Table 9. Global Gastric Motility Disorder Drug Sales Market Share by Region (2016-2021)

Table 10. Global Gastric Motility Disorder Drug Revenue by Region (2016-2021) & (US$ Million)

Table 11. Global Gastric Motility Disorder Drug Revenue Market Share by Region (2016-2021)

Table 12. Global Gastric Motility Disorder Drug Sales Forecast by Region (2022-2027) & (K Pcs)

Table 13. Global Gastric Motility Disorder Drug Sales Market Share Forecast by Region (2022-2027)

Table 14. Global Gastric Motility Disorder Drug Revenue Forecast by Region (2022-2027) & (US$ Million)

Table 15. Global Gastric Motility Disorder Drug Revenue Market Share Forecast by Region (2022-2027)

Table 16. Top Gastric Motility Disorder Drug Regions (Countries) Ranking by Market Size (US$ Million) in 2020

Table 17. Gastric Motility Disorder Drug Market Trends

Table 18. Gastric Motility Disorder Drug Market Drivers

Table 19. Gastric Motility Disorder Drug Market Challenges

Table 20. Gastric Motility Disorder Drug Market Restraints

Table 21. Global Gastric Motility Disorder Drug Sales by Manufacturers (2016-2021) & (K Pcs)

Table 22. Global Gastric Motility Disorder Drug Sales Share by Manufacturers (2016-2021)

Table 23. Global Gastric Motility Disorder Drug Revenue by Manufacturers (2016-2021) & (US$ Million)

Table 24. Ranking of Global Top Gastric Motility Disorder Drug Manufacturers by Revenue (US$ Million) in 2020

Table 25. Gastric Motility Disorder Drug Revenue Share by Manufacturers (2016-2021)

Table 26. Global Gastric Motility Disorder Drug Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 27. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Gastric Motility Disorder Drug as of 2020)

Table 28. Key Manufacturers Gastric Motility Disorder Drug Average Selling Price (ASP) & (2016-2021) & (USD/Pcs)

Table 29. Key Manufacturers Gastric Motility Disorder Drug Plants/Factories Distribution

Table 30. Key Manufacturers Gastric Motility Disorder Drug Area Served

Table 31. Date of Key Manufacturers Enter into Gastric Motility Disorder Drug Market

Table 32. Key Manufacturers Gastric Motility Disorder Drug Product Type

Table 33. Mergers & Acquisitions, Expansion Plans

Table 34. Global Gastric Motility Disorder Drug Sales (K Pcs) by Type (2016-2021)

Table 35. Global Gastric Motility Disorder Drug Sales Share by Type (2016-2021)

Table 36. Global Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Type (2016-2021)

Table 37. Global Gastric Motility Disorder Drug Price (K Pcs) by Type (2016-2021)

Table 38. Global Gastric Motility Disorder Drug Sales (K Pcs) by Type (2022-2027)

Table 39. Global Gastric Motility Disorder Drug Sales Share by Type (2022-2027)

Table 40. Global Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Type (2022-2027)

Table 41. Global Gastric Motility Disorder Drug Revenue Share by Type (2022-2027)

Table 42. Global Gastric Motility Disorder Drug Price (K Pcs) by Type (2022-2027)

Table 43. Global Gastric Motility Disorder Drug Sales (K Pcs) by Application (2016-2021)

Table 44. Global Gastric Motility Disorder Drug Sales Share by Application (2016-2021)

Table 45. Global Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Application (2016-2021)

Table 46. Global Gastric Motility Disorder Drug Price (K Pcs) by Application (2016-2021)

Table 47. Global Gastric Motility Disorder Drug Sales (K Pcs) by Application (2022-2027)

Table 48. Global Gastric Motility Disorder Drug Sales Share by Application (2022-2027)

Table 49. Global Gastric Motility Disorder Drug Revenue (US$ Million) Market Share by Application (2022-2027)

Table 50. Global Gastric Motility Disorder Drug Revenue Share by Application (2022-2027)

Table 51. Global Gastric Motility Disorder Drug Price (K Pcs) by Application (2022-2027)

Table 52. North America Gastric Motility Disorder Drug Sales by Company (2016-2021) & (K Pcs)

Table 53. North America Gastric Motility Disorder Drug Sales Market Share by Company (2016-2021)

Table 54. North America Gastric Motility Disorder Drug Revenue by Company (2016-2021) & (US$ Million)

Table 55. North America Gastric Motility Disorder Drug Revenue Market Share by Company (2016-2021)

Table 56. North America Gastric Motility Disorder Drug Sales by Application (2016-2021) & (K Pcs)

Table 57. North America Gastric Motility Disorder Drug Sales by Application (2022-2027) & (K Pcs)

Table 58. North America Gastric Motility Disorder Drug Revenue by Application (2016-2021) & (US$ Million)

Table 59. North America Gastric Motility Disorder Drug Revenue by Application (2022-2027) & (US$ Million)

Table 60. North America Gastric Motility Disorder Drug Sales by Application (2016-2021) & (K Pcs)

Table 61. North America Gastric Motility Disorder Drug Sales by Application (2022-2027) & (K Pcs)

Table 62. North America Gastric Motility Disorder Drug Revenue by Application (2016-2021) & (US$ Million)

Table 63. North America Gastric Motility Disorder Drug Revenue by Application (2022-2027) & (US$ Million)

Table 64. North America Gastric Motility Disorder Drug Sales by Country (2016-2021) & (K Pcs)

Table 65. North America Gastric Motility Disorder Drug Sales by Country (2022-2027) & (K Pcs)

Table 66. North America Gastric Motility Disorder Drug Revenue by Country (2016-2021) & (US$ Million)

Table 67. North America Gastric Motility Disorder Drug Revenue by Country (2022-2027) & (US$ Million)

Table 68. Europe Gastric Motility Disorder Drug Sales by Company (2016-2021) & (K Pcs)

Table 69. Europe Gastric Motility Disorder Drug Sales Market Share by Company (2016-2021)

Table 70. Europe Gastric Motility Disorder Drug Revenue by Company (2016-2021) & (US$ Million)

Table 71. Europe Gastric Motility Disorder Drug Revenue Market Share by Company (2016-2021)

Table 72. Europe Gastric Motility Disorder Drug Sales by Application (2016-2021) & (K Pcs)

Table 73. Europe Gastric Motility Disorder Drug Sales by Application (2022-2027) & (K Pcs)

Table 74. Europe Gastric Motility Disorder Drug Revenue by Application (2016-2021) & (US$ Million)

Table 75. Europe Gastric Motility Disorder Drug Revenue by Application (2022-2027) & (US$ Million)

Table 76. Europe Gastric Motility Disorder Drug Sales by Application (2016-2021) & (K Pcs)

Table 77. Europe Gastric Motility Disorder Drug Sales by Application (2022-2027) & (K Pcs)

Table 78. Europe Gastric Motility Disorder Drug Revenue by Application (2016-2021) & (US$ Million)

Table 79. Europe Gastric Motility Disorder Drug Revenue by Application (2022-2027) & (US$ Million)

Table 80. Europe Gastric Motility Disorder Drug Sales by Country (2016-2021) & (K Pcs)

Table 81. Europe Gastric Motility Disorder Drug Sales by Country (2022-2027) & (K Pcs)

Table 82. Europe Gastric Motility Disorder Drug Revenue by Country (2016-2021) & (US$ Million)

Table 83. Europe Gastric Motility Disorder Drug Revenue by Country (2022-2027) & (US$ Million)

Table 84. Asia Pacific Gastric Motility Disorder Drug Sales by Company (2016-2021) & (K Pcs)

Table 85. Asia Pacific Gastric Motility Disorder Drug Sales Market Share by Company (2016-2021)

Table 86. Asia Pacific Gastric Motility Disorder Drug Revenue by Company (2016-2021) & (US$ Million)

Table 87. Asia Pacific Gastric Motility Disorder Drug Revenue Market Share by Company (2016-2021)

Table 88. Asia Pacific Gastric Motility Disorder Drug Sales by Application (2016-2021) & (K Pcs)

Table 89. Asia Pacific Gastric Motility Disorder Drug Sales by Application (2022-2027) & (K Pcs)

Table 90. Asia Pacific Gastric Motility Disorder Drug Revenue by Application (2016-2021) & (US$ Million)

Table 91. Asia Pacific Gastric Motility Disorder Drug Revenue by Application (2022-2027) & (US$ Million)

Table 92. Asia Pacific Gastric Motility Disorder Drug Sales by Application (2016-2021) & (K Pcs)

Table 93. Asia Pacific Gastric Motility Disorder Drug Sales by Application (2022-2027) & (K Pcs)

Table 94. Asia Pacific Gastric Motility Disorder Drug Revenue by Application (2016-2021) & (US$ Million)

Table 95. Asia Pacific Gastric Motility Disorder Drug Revenue by Application (2022-2027) & (US$ Million)

Table 96. Asia Pacific Gastric Motility Disorder Drug Sales by Region (2016-2021) & (K Pcs)

Table 97. Asia Pacific Gastric Motility Disorder Drug Sales by Region (2022-2027) & (K Pcs)

Table 98. Asia Pacific Gastric Motility Disorder Drug Revenue by Region (2016-2021) & (US$ Million)

Table 99. Asia Pacific Gastric Motility Disorder Drug Revenue by Region (2022-2027) & (US$ Million)

Table 100. Latin America Gastric Motility Disorder Drug Sales by Company (2016-2021) & (K Pcs)

Table 101. Latin America Gastric Motility Disorder Drug Sales Market Share by Company (2016-2021)

Table 102. Latin America Gastric Motility Disorder Drug Revenue by Company (2016-2021) & (US$ Million)

Table 103. Latin America Gastric Motility Disorder Drug Revenue Market Share by Company (2016-2021)

Table 104. Latin America Gastric Motility Disorder Drug Sales by Application (2016-2021) & (K Pcs)

Table 105. Latin America Gastric Motility Disorder Drug Sales by Application (2022-2027) & (K Pcs)

Table 106. Latin America Gastric Motility Disorder Drug Revenue by Application (2016-2021) & (US$ Million)

Table 107. Latin America Gastric Motility Disorder Drug Revenue by Application (2022-2027) & (US$ Million)

Table 108. Latin America Gastric Motility Disorder Drug Sales by Application (2016-2021) & (K Pcs)

Table 109. Latin America Gastric Motility Disorder Drug Sales by Application (2022-2027) & (K Pcs)

Table 110. Latin America Gastric Motility Disorder Drug Revenue by Application (2016-2021) & (US$ Million)

Table 111. Latin America Gastric Motility Disorder Drug Revenue by Application (2022-2027) & (US$ Million)

Table 112. Latin America Gastric Motility Disorder Drug Sales by Country (2016-2021) & (K Pcs)

Table 113. Latin America Gastric Motility Disorder Drug Sales by Country (2022-2027) & (K Pcs)

Table 114. Latin America Gastric Motility Disorder Drug Revenue by Country (2016-2021) & (US$ Million)

Table 115. Latin America Gastric Motility Disorder Drug Revenue by Country (2022-2027) & (US$ Million)

Table 116. Middle East and Africa Gastric Motility Disorder Drug Sales by Company (2016-2021) & (K Pcs)

Table 117. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Company (2016-2021)

Table 118. Middle East and Africa Gastric Motility Disorder Drug Revenue by Company (2016-2021) & (US$ Million)

Table 119. Middle East and Africa Gastric Motility Disorder Drug Revenue Market Share by Company (2016-2021)

Table 120. Middle East and Africa Gastric Motility Disorder Drug Sales by Application (2016-2021) & (K Pcs)

Table 121. Middle East and Africa Gastric Motility Disorder Drug Sales by Application (2022-2027) & (K Pcs)

Table 122. Middle East and Africa Gastric Motility Disorder Drug Revenue by Application (2016-2021) & (US$ Million)

Table 123. Middle East and Africa Gastric Motility Disorder Drug Revenue by Application (2022-2027) & (US$ Million)

Table 124. Middle East and Africa Gastric Motility Disorder Drug Sales by Application (2016-2021) & (K Pcs)

Table 125. Middle East and Africa Gastric Motility Disorder Drug Sales by Application (2022-2027) & (K Pcs)

Table 126. Middle East and Africa Gastric Motility Disorder Drug Revenue by Application (2016-2021) & (US$ Million)

Table 127. Middle East and Africa Gastric Motility Disorder Drug Revenue by Application (2022-2027) & (US$ Million)

Table 128. Middle East and Africa Gastric Motility Disorder Drug Sales by Country (2016-2021) & (K Pcs)

Table 129. Middle East and Africa Gastric Motility Disorder Drug Sales by Country (2022-2027) & (K Pcs)

Table 130. Middle East and Africa Gastric Motility Disorder Drug Revenue by Country (2016-2021) & (US$ Million)

Table 131. Middle East and Africa Gastric Motility Disorder Drug Revenue by Country (2022-2027) & (US$ Million)

Table 132. Theravance, Inc. Corporation Information

Table 133. Theravance, Inc. Description and Overview

Table 134. Theravance, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 135. Theravance, Inc. Gastric Motility Disorder Drug Product and Services

Table 136. Theravance, Inc. Gastric Motility Disorder Drug SWOT Analysis

Table 137. Theravance, Inc. Recent Developments

Table 138. Helsinn Healthcare S.A. Corporation Information

Table 139. Helsinn Healthcare S.A. Description and Overview

Table 140. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 141. Helsinn Healthcare S.A. Gastric Motility Disorder Drug Product and Services

Table 142. Helsinn Healthcare S.A. Gastric Motility Disorder Drug SWOT Analysis

Table 143. Helsinn Healthcare S.A. Recent Developments

Table 144. Concert Pharmaceuticals, Inc. Corporation Information

Table 145. Concert Pharmaceuticals, Inc. Description and Overview

Table 146. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 147. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug Product and Services

Table 148. Concert Pharmaceuticals, Inc. Gastric Motility Disorder Drug SWOT Analysis

Table 149. Concert Pharmaceuticals, Inc. Recent Developments

Table 150. Targacept, Inc. Corporation Information

Table 151. Targacept, Inc. Description and Overview

Table 152. Targacept, Inc. Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 153. Targacept, Inc. Gastric Motility Disorder Drug Product and Services

Table 154. Targacept, Inc. Gastric Motility Disorder Drug SWOT Analysis

Table 155. Targacept, Inc. Recent Developments

Table 156. ChironWells GmbH Corporation Information

Table 157. ChironWells GmbH Description and Overview

Table 158. ChironWells GmbH Gastric Motility Disorder Drug Sales (K Pcs), Revenue (Million US$), Average Selling Price (ASP) (USD/Pcs) and Gross Margin (2016-2021)

Table 159. ChironWells GmbH Gastric Motility Disorder Drug Product and Services

Table 160. ChironWells GmbH Gastric Motility Disorder Drug SWOT Analysis

Table 161. ChironWells GmbH Recent Developments

Table 162. Key Raw Materials Lists

Table 163. Raw Materials Key Suppliers Lists

Table 164. Gastric Motility Disorder Drug Distributors List

Table 165. Gastric Motility Disorder Drug Customers List

Table 166. Research Programs/Design for This Report

Table 167. Key Data Information from Secondary Sources

Table 168. Key Data Information from Primary Sources

List of Figures

Figure 1. Gastric Motility Disorder Drug Product Picture

Figure 2. Global Gastric Motility Disorder Drug Sales Market Share by Type in 2020 & 2027

Figure 3. Velusetrag Picture

Figure 4. Ipamorelin Picture

Figure 5. TD-8954 Picture

Figure 6. Others Picture

Figure 7. Global Gastric Motility Disorder Drug Sales Market Share by Application in 2020 & 2027

Figure 8. Hospital Use Case

Figure 9. Clinic Use Case

Figure 10. Home Use Use Case

Figure 11. Gastric Motility Disorder Drug Report Years Considered

Figure 12. Global Gastric Motility Disorder Drug Revenue, (US$ Million), 2016 VS 2021 VS 2027

Figure 13. Global Gastric Motility Disorder Drug Market Size 2016-2027 (US$ Million)

Figure 14. Global Gastric Motility Disorder Drug Sales (2016-2021) & (K Pcs)

Figure 15. Global Gastric Motility Disorder Drug Market Size Market Share by Region: 2020 VS 2027

Figure 16. Global Gastric Motility Disorder Drug Sales Market Share by Region (2016-2021)

Figure 17. Global Gastric Motility Disorder Drug Sales Market Share by Region in 2020

Figure 18. Global Gastric Motility Disorder Drug Revenue Market Share by Region in 2016 VS 2020

Figure 19. Global Gastric Motility Disorder Drug Sales Share by Manufacturers In 2020

Figure 20. The 5 and 10 Largest Manufacturers in the World: Market Share by Gastric Motility Disorder Drug Sales in 2020

Figure 21. Gastric Motility Disorder Drug Revenue Share by Manufacturers In 2020

Figure 22. Gastric Motility Disorder Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020

Figure 23. Global Gastric Motility Disorder Drug Revenue Share by Type (2016-2021)

Figure 24. Global Gastric Motility Disorder Drug Revenue Growth Rate by Type in 2016 & 2020

Figure 25. Global Gastric Motility Disorder Drug Revenue Share by Application (2016-2021)

Figure 26. Global Gastric Motility Disorder Drug Revenue Growth Rate by Application in 2016 & 2020

Figure 27. North America Gastric Motility Disorder Drug Sales Market Share by Type (2016-2027)

Figure 28. North America Gastric Motility Disorder Drug Revenue Market Share by Type (2016-2027)

Figure 29. North America Gastric Motility Disorder Drug Sales Market Share by Application (2016-2027)

Figure 30. North America Gastric Motility Disorder Drug Revenue Market Share by Application (2016-2027)

Figure 31. North America Gastric Motility Disorder Drug Sales Share by Country (2016-2027)

Figure 32. North America Gastric Motility Disorder Drug Revenue Share by Country (2016-2027)

Figure 33. U.S. Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 34. Canada Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 35. Europe Gastric Motility Disorder Drug Sales Market Share by Type (2016-2027)

Figure 36. Europe Gastric Motility Disorder Drug Revenue Market Share by Type (2016-2027)

Figure 37. Europe Gastric Motility Disorder Drug Sales Market Share by Application (2016-2027)

Figure 38. Europe Gastric Motility Disorder Drug Revenue Market Share by Application (2016-2027)

Figure 39. Europe Gastric Motility Disorder Drug Sales Share by Country (2016-2027)

Figure 40. Europe Gastric Motility Disorder Drug Revenue Share by Country (2016-2027)

Figure 41. Germany Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 42. France Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 43. U.K. Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 44. Italy Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 45. Russia Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 46. Asia Pacific Gastric Motility Disorder Drug Sales Market Share by Type (2016-2027)

Figure 47. Asia Pacific Gastric Motility Disorder Drug Revenue Market Share by Type (2016-2027)

Figure 48. Asia Pacific Gastric Motility Disorder Drug Sales Market Share by Application (2016-2027)

Figure 49. Asia Pacific Gastric Motility Disorder Drug Revenue Market Share by Application (2016-2027)

Figure 50. Asia Pacific Gastric Motility Disorder Drug Sales Share by Region (2016-2027)

Figure 51. Asia Pacific Gastric Motility Disorder Drug Revenue Share by Region (2016-2027)

Figure 52. China Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 53. Japan Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 54. South Korea Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 55. India Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 56. Australia Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 57. Taiwan Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 58. Indonesia Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 59. Thailand Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 60. Malaysia Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 61. Philippines Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 62. Vietnam Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 63. Latin America Gastric Motility Disorder Drug Sales Market Share by Type (2016-2027)

Figure 64. Latin America Gastric Motility Disorder Drug Revenue Market Share by Type (2016-2027)

Figure 65. Latin America Gastric Motility Disorder Drug Sales Market Share by Application (2016-2027)

Figure 66. Latin America Gastric Motility Disorder Drug Revenue Market Share by Application (2016-2027)

Figure 67. Latin America Gastric Motility Disorder Drug Sales Share by Country (2016-2027)

Figure 68. Latin America Gastric Motility Disorder Drug Revenue Share by Country (2016-2027)

Figure 69. Mexico Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 70. Brazil Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 71. Argentina Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 72. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Type (2016-2027)

Figure 73. Middle East and Africa Gastric Motility Disorder Drug Revenue Market Share by Type (2016-2027)

Figure 74. Middle East and Africa Gastric Motility Disorder Drug Sales Market Share by Application (2016-2027)

Figure 75. Middle East and Africa Gastric Motility Disorder Drug Revenue Market Share by Application (2016-2027)

Figure 76. Middle East and Africa Gastric Motility Disorder Drug Sales Share by Country (2016-2027)

Figure 77. Middle East and Africa Gastric Motility Disorder Drug Revenue Share by Country (2016-2027)

Figure 78. Turkey Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 79. Saudi Arabia Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 80. UAE Gastric Motility Disorder Drug Revenue (2016-2027) & (US$ Million)

Figure 81. Gastric Motility Disorder Drug Value Chain

Figure 82. Gastric Motility Disorder Drug Production Process

Figure 83. Channels of Distribution

Figure 84. Distributors Profiles

Figure 85. Bottom-up and Top-down Approaches for This Report

Figure 86. Data Triangulation

Figure 87. Key Executives Interviewed